about
The role of ANGPTL3 in controlling lipoprotein metabolismRole of mitochondria in nonalcoholic fatty liver diseaseEmerging risk biomarkers in cardiovascular diseases and disordersClinicopathological Phenotype of Autosomal Recessive Cholesterol Deficiency in Holstein CattleAssociation between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.A successful spontaneous pregnancy in abetalipoproteinemia: Amsterdam or the art of vitamin replacement?Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial HypobetalipoproteinemiaMTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014.Clinical utility gene card for: Abetalipoproteinaemia--Update 2014.Pathogenesis and Prevention of Hepatic Steatosis.Insights from human congenital disorders of intestinal lipid metabolism.Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.Can LDL cholesterol be too low? Possible risks of extremely low levels.Cancer Chemotherapy Specific to Acidic Nests.Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D.Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD.Overview and introduction: thematic review series on intestinal lipid metabolism.Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levelsPrevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.Triglyceride Metabolism in the Liver.Hypercholesterolaemia - practical information for non-specialists.New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Complex genetic architecture in severe hypobetalipoproteinemia.Cardiovascular Implications of Sphingomyelin Presence in Biological MembranesExome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populationsInduction of Liver Steatosis in BAP31-Deficient Mice Burdened with Tunicamycin-Induced Endoplasmic Reticulum StressClinical significance of APOB inactivation in hepatocellular carcinoma
P2860
Q26769679-660B8AD8-1291-454F-9104-DA44F23A8610Q27028142-314AFA8F-D20A-437D-9D87-61A1E65E5C50Q28081614-14AF73B7-3CF5-4C3C-B333-885DC5183498Q28822508-4D54A701-2941-4CA4-9642-147DE807F6F1Q30241977-9611DE00-3CCD-4040-AB6B-3052504341F4Q34691979-A78BEFBD-0C79-471E-A8D2-1525B24EAFA4Q35801021-4781FC38-A4C0-4B7A-8479-455DD9D73736Q35803568-CB339946-2C68-4F17-9E8A-7A3C2C0F48B2Q36695217-C4B169C7-5B64-4EFA-8C1C-BE1C9C9CC5E6Q36695239-23A8C799-18B3-4A63-AC69-A151856CAE6EQ36812508-38DC5FCF-F23B-44E4-85D3-814C124AC18DQ38267212-05926376-9EE3-4746-A779-FC8F2D63D49DQ39070311-340CCC47-32F3-4996-80E4-7206779AC94EQ39179689-81D73D89-1133-4822-8B71-B2F44FBE70CEQ39251854-6082E0CA-05B0-4458-81F1-E29EE2A27CFFQ39298579-ED000B10-0E92-45B7-AC7E-ADC7A0AA0851Q41675408-A3582442-124C-49A6-9ADA-C4CDDDDC46D9Q42598675-A8412746-5A03-463F-B96E-67BC800183D3Q42696093-CDBBC7AB-6287-479E-9623-84C748AB30BCQ46457925-57D78DED-56E6-4825-8397-541A3D91F336Q47719467-C9840916-7901-4CAE-9EE9-08A3A38EFE7EQ49592460-B8C632A8-C4D1-4365-82D7-AD05EFED9241Q50044216-BCD6B319-17BE-409B-85DC-0D26182BEAD5Q52355653-9B9912BB-3492-4AA9-AA93-107BDB7E8D15Q57495845-F9B01605-D37A-462C-82F4-2967C4BF8E67Q58751735-2AD13A9C-759C-4C45-85DE-49A6ACFBB869Q58800423-E06CBE89-397C-4DC4-8815-9270A90D9B34Q59131869-6AAA4714-A4F8-4F8F-87F6-A3FD7BFBD424
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hypobetalipoproteinemia and abetalipoproteinemia.
@ast
Hypobetalipoproteinemia and abetalipoproteinemia.
@en
type
label
Hypobetalipoproteinemia and abetalipoproteinemia.
@ast
Hypobetalipoproteinemia and abetalipoproteinemia.
@en
prefLabel
Hypobetalipoproteinemia and abetalipoproteinemia.
@ast
Hypobetalipoproteinemia and abetalipoproteinemia.
@en
P2860
P1476
Hypobetalipoproteinemia and abetalipoproteinemia.
@en
P2093
Francine K Welty
P2860
P304
P356
10.1097/MOL.0000000000000072
P577
2014-06-01T00:00:00Z